Company
United StatesPublic company, NYSE: BSXBoston Scientific Corporation (NYSE: BSX), Cambridge, MA – FDA Inspections
Inspection records and compliance data for Boston Scientific Corporation in Cambridge, MA. 1 FDA inspection on record, last inspected July 13, 2017. Publicly traded as NYSE: BSX.
Company Profile
This profile covers Boston Scientific Corporation based in Cambridge, MA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected July 13, 2017.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 13, 2017 | Not classified | Medical Devices & Rad Health | 1037126 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Lawrence General Hospital
Greater Lawrence Family Health Center
Lowell General Hospital
St Vincent Hospital at Auburn Grove Medical
Harvard Vangaurd Medical Associates
Northern Berkshire Health Center of Berkshire Medical Center
HALLMARK HEALTH MEDICAL CENTER
Massachusetts General Hospital
East Boston Neighborhood Health Center
Southcoast Hospitals Group Radiology Services
Company Information
Name
Boston Scientific Corporation
Stock ticker
BSX
Exchange
NYSE
Share price
$44.61
Market cap
$64.7B
Price as of
November 6, 2026
FEI Number
3010705768
Address
125 Cambridgepark Dr Ste 600, Cambridge, MA 02140-2329, United States
Country
United States
ID: e775ad3d-9e94-4018-8ef8-b2e7ebb5fe14